About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0689 USD | +53.11% | +70.98% | -65.28% |
05-13 | Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index | CI |
05-09 | Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M | MT |
About
Acutus is focused on the production of left-heart access products under its distribution agreement with
Investor Contact: |
D: 442-232-6080 |
investors@acutus.com |
Source:
2023 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-65.28% | 1.34M | |
+10.95% | 127B | |
-5.10% | 11.32B | |
+4.02% | 9.04B | |
+36.97% | 5.56B | |
-24.05% | 4.72B | |
+8.54% | 3.45B | |
-6.78% | 2.86B | |
-5.85% | 2.07B | |
-11.84% | 2.04B |